| 1 |
2024 |
Jihyun Baek, Joonhong Jun, Hyejin Kim, Hyunah Bae, Haebeen Park, Hyunwook Cho, Songhee Han, Ho Chul Shin, Jung-Mi Hah. Targeting the CSF-1/CSF-1R Axis: Exploring the Potential of CSF1R Inhibitors in Neurodegenerative Diseases, Journal of Medicinal Chemistry. 2024; 67: 5699.
https://doi.org/10.1021/acs.jmedchem.3c02366 |
| 2 |
2025 |
ATHIRA SASIDHARAN, DEEPTHI K., SHESHAGIRI DIXIT, DEEPSHIKHA SINGH, VEENA V. TOM, YOGISH SOMAYAJI, RONALD FERNANDES. IN SILICO EVALUATION OF CSF1R INHIBITORS: A PROMISING APPROACH FOR TARGETING NEUROINFLAMMATION IN NEURODEGENERATIVE DISEASES, International Journal of Applied Pharmaceutics. 2025; 268.
https://doi.org/10.22159/ijap.2025v17i2.53425 |
| 3 |
2025 |
Srinivasulu Cherukupalli, Carsten Degenhart, Peter Habenberger, Anke Unger, Jan Eickhoff, Bård Helge Hoff, Eirik Sundby. Design and Synthesis of Pyridine-Based Pyrrolo[2,3-d]pyrimidine Analogs as CSF1R Inhibitors: Molecular Hybridization and Scaffold Hopping Approach, Pharmaceuticals. 2025; 18: 814.
https://doi.org/10.3390/ph18060814 |
| 4 |
2024 |
Chompunud Chompunud Na Ayudhya, Potchanapond Graidist, Varomyalin Tipmanee. Role of CSF1R 550th-tryptophan in kusunokinin and CSF1R inhibitor binding and ligand-induced structural effect, Scientific Reports. 2024; 14: 12531.
https://doi.org/10.1038/s41598-024-63505-x |
